Abstract Number: 1130 • 2012 ACR/ARHP Annual Meeting
The Effect of Age On the Number of Osteoarthritis Flares with Continuous Versus Intermittent Celecoxib Treatment
Background/Purpose: Continuous nonsteroidal anti-inflammatory drug (NSAID) treatment is significantly more efficacious than intermittent dosing1during 22-weeks in preventing flares in patients with osteoarthritis (OA) of the…Abstract Number: 1131 • 2012 ACR/ARHP Annual Meeting
Intraarticular Infliximab for Knee Osteoarthritis: High Baseline Levels of Synovial Cellularity and High MRI Cartilage Injury At the Lateral Tibial Plateau Predict Improvement in Total WOMAC Score
Background/Purpose: Synovial tissue from patients with OA often demonstrates inflammation. We hypothesized that a single intraarticular (IA) injection of an anti-TNF drug would decrease inflammatory…Abstract Number: 1132 • 2012 ACR/ARHP Annual Meeting
Prevalence of Knee Pain in Ultramarathon Runners
Prevalence of Knee Pain in Ultramarathon Runners Background/Purpose: Approximately one in four Americans suffer from frequent knee pain. While some studies have linked long-distance running…Abstract Number: 1133 • 2012 ACR/ARHP Annual Meeting
Gait Differences Are Present in Subjects with Symptomatic Vs. Asymptomatic Mild Radiographic Hip Osteoarthritis
Background/Purpose: It is known that joint mechanics are involved in the hip osteoarthritis (OA) disease process. In a previous study1, several gait variables were lower…Abstract Number: 1134 • 2012 ACR/ARHP Annual Meeting
What Are the Levels of Physical Activities and Their Associations with Quality of Life in Patients with Symptomatic Hip and/or Knee Osteoarthritis?
Background/Purpose: Physical activities (PA) practice is recommended by numerous public health organizations. According to international recommendations, patients with hip and knee osteoarthritis (OA) should be…Abstract Number: 1135 • 2012 ACR/ARHP Annual Meeting
Combined Glucosamine and Chondroitin Sulfate, Once of Three Times Daily, Provide Clinically Relevant Analgesia in Knee Osteoarthritis
Background/Purpose: The analgesic efficacy of combined glucosamine and chondroitin sulfate (CS) in knee osteoarthritis (OA) remains controversial. Criticism to previous studies includes small sample size,…Abstract Number: 1096 • 2012 ACR/ARHP Annual Meeting
Lower Income Paradoxically Associated with Better Patient-Reported Outcomes After Knee Arthroplasty in the U.S
Background/Purpose: To assess whether income is associated with patient-reported outcomes (PROs) after primary total knee arthroplasty (TKA).Methods: We used the prospectively collected data from…Abstract Number: 1097 • 2012 ACR/ARHP Annual Meeting
The Association of Fat Distribution and Clinically Defined Hand Osteoarthritis: The Netherlands Epidemiology of Obesity Study
Background/Purpose: Obesity, assessed as body mass index (BMI) ≥ 30 kg/m2, is an important risk factor for osteoarthritis (OA). BMI depends only upon height and…Abstract Number: 1098 • 2012 ACR/ARHP Annual Meeting
Knee Osteoarthritis and Frailty in Older Adults: Findings From the Multicenter Osteoarthritis Study and Osteoarthritis Initiative
Background/Purpose: Both knee osteoarthritis (OA) and the frailty syndrome affect older adults and both are associated with functional limitation and disability. Frailty in elders is…Abstract Number: 1099 • 2012 ACR/ARHP Annual Meeting
Whole Blood Lead Is Associated with Symptoms, but Not Radiographic Osteoarthritis, in Multiple Joint Sites: The Johnston County Osteoarthritis Project
Background/Purpose: We have previously identified associations between whole blood lead (Pb) and knee osteoarthritis (OA) and with biomarkers of joint metabolism. We hypothesized that Pb…Abstract Number: 1100 • 2012 ACR/ARHP Annual Meeting
A Functional Growth Hormone Receptor Polymorphism, Exon 3 Deleted Ghr, Is Associated with Radiographic Knee Osteoarthritis in Females with Familial Osteoarthritis At Multiple Sites: The Garp Study
Background/Purpose: Genetic influences contribute considerably to the development of osteoarthritis (OA), and are most likely of a polygenic nature. Until now, genetic studies have identified…Abstract Number: 1101 • 2012 ACR/ARHP Annual Meeting
Condroitin Sulfate Decreases Chemokine Levels and Synovitis in knee osteoarthritis Patients
Background/Purpose: Synovitis is one of the major signs of structure damage in osteoarthritis (OA) progression. Chondroitin sulfate (CS) is an effective drug in the treatment…Abstract Number: 1102 • 2012 ACR/ARHP Annual Meeting
Immunoreactive Collagen Type II Cleavage Products and Their Nitrated Forms in Rheumatoid Arthritis and Osteoarthritis: An Outpatient Cross-Sectional Study
Background/Purpose: Catabolism of type II collagen (COLII) involves multiple metalloproteinases, aggrecanases and cathepsin, releasing heterogeneous triple helix cleavage products. The complex regulation of these enzymes and of inducible…Abstract Number: 1103 • 2012 ACR/ARHP Annual Meeting
Cumulative Occupational Physical Load As Risk Factor for Knee Osteoarthritis
Background/Purpose: Knee osteoarthritis (OA) results from the interaction of multiple risk factors, one of which may be physically demanding occupations. The purpose of this study…Abstract Number: 1104 • 2012 ACR/ARHP Annual Meeting
The Association of Demographic, Modifiable, Structural and Biomechanical Risk Factors with Medial and Lateral Patellofemoral Joint Structural Damage On MRI: The Multicenter Osteoarthritis Study
Background/Purpose: Past investigations into risk factors for patellofemoral joint (PFJ) osteoarthritis (OA) have been limited by the use of radiography, which is insensitive to identify…